BRPI0416744A - sistemas de expressão de proteìna aperfeiçoados - Google Patents

sistemas de expressão de proteìna aperfeiçoados

Info

Publication number
BRPI0416744A
BRPI0416744A BRPI0416744-9A BRPI0416744A BRPI0416744A BR PI0416744 A BRPI0416744 A BR PI0416744A BR PI0416744 A BRPI0416744 A BR PI0416744A BR PI0416744 A BRPI0416744 A BR PI0416744A
Authority
BR
Brazil
Prior art keywords
expression systems
protein expression
improved
improved protein
present
Prior art date
Application number
BRPI0416744-9A
Other languages
English (en)
Inventor
Jane C Schneider
Lawrence C Chew
Anne Kathryn Badgley
Thomas Martin Ramseier
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Publication of BRPI0416744A publication Critical patent/BRPI0416744A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/78—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/05—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
    • C12Y305/05001—Nitrilase (3.5.5.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

"SISTEMAS DE EXPRESSãO DE PROTEìNA APERFEIçOADOS". A presente invenção refere-se a um sistema de expressão aperfeiçoado para a produção de um polipeptídeo recombinante utilizando marcadores selecionáveis auxotróficos. Além disso, a presente invenção proporciona a produção aperfeiçoada de proteína recombinante em células hospedeiras através de regulação aperfeiçoada de expressão.
BRPI0416744-9A 2003-11-19 2004-11-19 sistemas de expressão de proteìna aperfeiçoados BRPI0416744A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52342003P 2003-11-19 2003-11-19
US53714704P 2004-01-16 2004-01-16
PCT/US2004/038884 WO2005052151A1 (en) 2003-11-19 2004-11-19 Improved protein expression systems

Publications (1)

Publication Number Publication Date
BRPI0416744A true BRPI0416744A (pt) 2007-01-16

Family

ID=34636466

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416744-9A BRPI0416744A (pt) 2003-11-19 2004-11-19 sistemas de expressão de proteìna aperfeiçoados

Country Status (10)

Country Link
US (2) US20050186666A1 (pt)
EP (1) EP1692282B1 (pt)
JP (2) JP5087741B2 (pt)
KR (1) KR101237651B1 (pt)
CN (1) CN1906294B (pt)
AU (1) AU2004293810B2 (pt)
BR (1) BRPI0416744A (pt)
CA (1) CA2545610C (pt)
MX (1) MXPA06005634A (pt)
WO (1) WO2005052151A1 (pt)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
CN1906294B (zh) 2003-11-19 2013-09-11 陶氏环球技术公司 改良的蛋白表达系统
JP2008507294A (ja) 2004-07-26 2008-03-13 ダウ グローバル テクノロジーズ インコーポレイティド 菌株遺伝子操作による改善されたタンパク質発現のための方法
RU2415935C2 (ru) * 2005-10-06 2011-04-10 ДОМПЕ ФА.Р.МА С.п.А. Новая система селекции
WO2007055789A2 (en) * 2005-10-31 2007-05-18 Neose Technologies, Inc. Expression of soluble therapeutic proteins
GB0602173D0 (en) * 2006-02-03 2006-03-15 Avecia Ltd Expression system
WO2007120932A2 (en) 2006-04-19 2007-10-25 Neose Technologies, Inc. Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms
WO2007142954A2 (en) * 2006-05-30 2007-12-13 Dow Global Technologies Inc. Codon optimization method
KR100824541B1 (ko) * 2007-02-26 2008-04-24 고려대학교 산학협력단 항산화 효소의 과발현을 통해 환경오염물질 분해능이향상된 균주
EP2142651B1 (en) 2007-04-27 2013-05-22 Pfenex Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CA2706639A1 (en) * 2007-11-29 2009-06-04 Novozymes A/S Synthase inhibitor screening method
JP2011505147A (ja) * 2007-11-30 2011-02-24 スカラブ ゲノミクス， エルエルシー ｌａｃ発現システム
WO2010008764A1 (en) * 2008-06-23 2010-01-21 Dow Global Technologies Inc. Pseudomonas fluorescens strains for production of extracellular recombinant protein
JP2010017131A (ja) * 2008-07-10 2010-01-28 Mitsui Eng & Shipbuild Co Ltd モーレラ属細菌及びプライマー
US8198062B2 (en) 2008-08-29 2012-06-12 Dsm Ip Assets B.V. Hydrolases, nucleic acids encoding them and methods for making and using them
US8357503B2 (en) 2008-08-29 2013-01-22 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
US8153391B2 (en) 2008-08-29 2012-04-10 Bunge Oils, Inc. Hydrolases, nucleic acids encoding them and methods for making and using them
US8623652B2 (en) * 2009-04-06 2014-01-07 Lucigen Corporation Host-vector system for cloning and expressing genes
WO2010132341A2 (en) 2009-05-11 2010-11-18 Pfenex, Inc. Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
UA109884C2 (uk) 2009-10-16 2015-10-26 Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
UA111708C2 (uk) 2009-10-16 2016-06-10 Бандж Ойлз, Інк. Спосіб рафінування олії
RU2573909C2 (ru) 2010-03-04 2016-01-27 Пфенекс Инк. Способ получения растворимого рекомбинантного белка интерферона без денатурирования
WO2011126811A2 (en) 2010-03-30 2011-10-13 Pfenex Inc. High level expression of recombinant toxin proteins
AU2011235210B2 (en) 2010-04-01 2015-07-16 Pfenex Inc. Methods for G-CSF production in a Pseudomonas host cell
EP4242320A3 (en) * 2010-07-12 2023-11-29 Inbiose N.V. Metabolically engineered organisms for the production of added value bio-products
DK3366697T3 (da) 2010-08-10 2021-03-29 Sachdev Sidhu Specifikke aktive stedshæmmere af enzymer eller substratbindingspartnere og fremgangsmåde til fremstilling heraf
PL222067B1 (pl) * 2011-08-11 2016-06-30 Inst Biotechnologii I Antybiotyków Kaseta ekspresyjna, zastosowanie kasety ekspresyjnej, wektor ekspresyjny, komórka prokariotycznego gospodarza zawierająca wektor ekspresyjny, szczep bakteryjny oraz sposób wytwarzania polipeptydu
EA028648B1 (ru) 2012-03-30 2017-12-29 Басф Энзаймс Ллк Ген, кодирующий целлюлазу (варианты)
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
WO2014047625A1 (en) * 2012-09-24 2014-03-27 Montana State University Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use
JP6448909B2 (ja) * 2013-03-01 2019-01-09 学校法人関西学院 目的遺伝子を欠損した酢酸菌の製造方法及びその利用
GB201308853D0 (en) 2013-03-12 2013-07-03 Verenium Corp Genes encoding xylanase
GB201308828D0 (en) 2013-03-12 2013-07-03 Verenium Corp Phytase
GB201308843D0 (en) 2013-03-14 2013-07-03 Verenium Corp Phytase formulation
AR095173A1 (es) 2013-07-25 2015-09-30 Basf Enzymes Llc Fitasa
CA2951152A1 (en) 2014-06-06 2015-12-10 The Hospital For Sick Children Soluble bacterial and fungal proteins and methods and uses thereof in inhibiting and dispersing biofilm
CN104004760B (zh) * 2014-06-12 2017-11-28 华东理工大学 一种用于在米曲霉细胞分泌表达外源蛋白的表达设备及其米曲霉基因工程菌
EP3161140A4 (en) 2014-06-27 2017-12-20 National Research Council of Canada Cannabichromenic acid synthase from cannabis sativa
US10316322B2 (en) 2014-07-02 2019-06-11 Sutro Biopharma, Inc. High growth capacity auxotrophic Escherichia coli and methods of use
MX2017006866A (es) 2014-12-01 2017-11-15 Pfenex Inc Pares de unión para producción de péptidos.
US11446366B2 (en) 2015-02-05 2022-09-20 Canem Holdings, Llc Compositions and methods for treating granulomatosis with polyangiitis
KR20170068304A (ko) * 2015-12-09 2017-06-19 삼성전자주식회사 대장균 및 코마가타에이박터 속 세포에서 복제가능한 벡터, 그를 포함한 세포, 및 그를 이용하는 방법
EP3688149A1 (en) 2017-09-26 2020-08-05 Bunge Global Innovation, LLC. Enzymatic removal of chlorophyll substrates from triacylglycerol-based oils
AU2018354069A1 (en) 2017-10-27 2020-06-11 Pelican Technology Holdings, Inc. Bacterial leader sequences for periplasmic protein expression
EP3700921A4 (en) 2017-10-27 2021-12-15 Pfenex Inc. PROCESS FOR THE PRODUCTION OF RECOMBINANT ERWINIA ASPARAGINASE
CN108504677B (zh) * 2018-03-06 2020-05-12 上海晶诺生物科技有限公司 一个用于构建谷氨酸基因家族缺失结核分枝杆菌的重组tm4噬菌体文库及其应用
EP3946720A1 (en) 2019-03-27 2022-02-09 Bunge Global Innovation, LLC. Silica adsorbent treatment for removal of chlorophyll derivatives from triacylglycerol-based oils
WO2020243642A2 (en) * 2019-05-31 2020-12-03 The Trustees Of Columbia University In The City Of New York Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof
CN111041029B (zh) * 2019-12-23 2022-05-10 中国科学院天津工业生物技术研究所 一种强启动子及其在产维生素b12菌株中的应用
CN113025601B (zh) * 2019-12-25 2024-06-21 上海奥博生物医药股份有限公司 腈水解酶启动子优化表达及应用
US12098372B2 (en) 2019-12-30 2024-09-24 Eligo Bioscience Microbiome modulation of a host by delivery of DNA payloads with minimized spread
US11746352B2 (en) 2019-12-30 2023-09-05 Eligo Bioscience Microbiome modulation of a host by delivery of DNA payloads with minimized spread
CN112080451A (zh) * 2020-07-13 2020-12-15 宁波大学 一种嗜酸乳杆菌的食品级基因表达体系及其制备方法和应用
WO2022144382A1 (en) 2020-12-30 2022-07-07 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase
JP2024520940A (ja) 2021-05-12 2024-05-27 エリゴ・バイオサイエンス 産生細菌細胞及び産生方法におけるその使用
WO2024211833A2 (en) 2023-04-05 2024-10-10 Primrose Bio, Inc. Methods and compositions for nucleic acid synthesis

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511503A (en) 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4680264A (en) 1983-07-01 1987-07-14 Lubrizol Genetics, Inc. Class II mobilizable gram-negative plasmid
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
DK594084A (da) * 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5232840A (en) * 1986-03-27 1993-08-03 Monsanto Company Enhanced protein production in bacteria by employing a novel ribosome binding site
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
US5169760A (en) * 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
JP2600090B2 (ja) 1991-04-19 1997-04-16 農林水産省農業環境技術研究所長 宿主ベクター系
US6566121B1 (en) * 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
US5691185A (en) * 1993-10-08 1997-11-25 Chr. Hansen A/S Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria
US5527883A (en) 1994-05-06 1996-06-18 Mycogen Corporation Delta-endotoxin expression in pseudomonas fluorescens
WO1997004110A1 (en) 1995-07-14 1997-02-06 Somatogen, Inc. Methods for increasing protein expression
AU1467399A (en) 1997-11-20 1999-06-15 William Marsh Rice University Lactose repressor proteins with altered ligand responsivity
US7390645B2 (en) * 1997-11-20 2008-06-24 William Marsh Rice University Lactose repressor proteins with increased operator DNA binding affinity
DE19801120A1 (de) * 1998-01-15 1999-07-22 Basf Ag Orotidin-5'-Phosphatdecarboxylase-Gen, Genkonstrukt enthaltend dieses Gen und seine Verwendung
JP4320689B2 (ja) 1998-06-16 2009-08-26 株式会社力王 履物用先芯
US6291245B1 (en) * 1998-07-15 2001-09-18 Roche Diagnostics Gmbh Host-vector system
EP0972838B1 (en) * 1998-07-15 2004-09-15 Roche Diagnostics GmbH Escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
WO2002086098A2 (en) * 2001-03-05 2002-10-31 University Of Virginia Patent Foundation A lac operator-repressor system
US20040005676A1 (en) * 2002-01-23 2004-01-08 Diversa Corporation Biocatalytic reduction of nitro groups
AU2002306484A1 (en) * 2002-02-13 2003-09-04 Dow Global Technologies Inc. Over-expression of extremozyme genes in pseudomonads and closely related bacteria
DE10214406A1 (de) * 2002-03-30 2003-10-09 Nutrinova Gmbh Verfahren und Marker zur einfachen Transformation und Selektion von rekombinanten Protisten
KR20050016362A (ko) * 2002-04-22 2005-02-21 다우 글로벌 테크놀로지스 인크. 펩티드의 저비용 생산
CN1906294B (zh) 2003-11-19 2013-09-11 陶氏环球技术公司 改良的蛋白表达系统

Also Published As

Publication number Publication date
JP2012100669A (ja) 2012-05-31
CA2545610A1 (en) 2005-06-09
CA2545610C (en) 2014-03-25
EP1692282A4 (en) 2008-04-02
US8288127B2 (en) 2012-10-16
EP1692282A1 (en) 2006-08-23
AU2004293810B2 (en) 2010-07-01
KR101237651B1 (ko) 2013-02-27
CN1906294B (zh) 2013-09-11
CN1906294A (zh) 2007-01-31
US20090325230A1 (en) 2009-12-31
KR20060132587A (ko) 2006-12-21
WO2005052151A1 (en) 2005-06-09
US20050186666A1 (en) 2005-08-25
JP2007511238A (ja) 2007-05-10
JP5087741B2 (ja) 2012-12-05
EP1692282B1 (en) 2012-08-08
AU2004293810A1 (en) 2005-06-09
MXPA06005634A (es) 2006-08-23

Similar Documents

Publication Publication Date Title
BRPI0416744A (pt) sistemas de expressão de proteìna aperfeiçoados
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
DE60235039D1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
CY1114944T1 (el) Σταθεροποιημενα αλφα ελικοειδη πεπτιδια και χρησεις αυτων
TNSN08064A1 (en) Albumin fusion proteins
NO20063026L (no) Antistoffer
BRPI0516176A (pt) polipeptìdeo, dna, microorganismo, e, processo para produzir l-arginina, l-ornitina ou l-citrulina
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
IN2014CN02050A (pt)
DK1525320T3 (da) Fremgangsmåde til ekspression af rekombinant protein i CHO-celler
BR0311693A (pt) Sal de formato de o-desmetil-venlafaxina
CU23608A3 (es) Vacuna para la tuberculosis ureasa deficiente con eficacia mejorada
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
ATE474926T1 (de) Verwendung von clya hemolysin fur ausscheidung von fusionprotein
MX2017010359A (es) Cadena alfa del receptor de inmunoglobulina e (ige) de alta afinidad de fusion de fragmento cristalizable (fc).
DE60331224D1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
DE60322613D1 (de) Frostschutzproteine aus Basidiomyceten
BR0214542A (pt) Célula hospedeira, sistema de expressão, e, processos de preparação de uma célula hospedeira, e de uma proteìna alvo
DE60025467D1 (de) Oxalacetat-hydrolase defiziente fungale wirtszellen
DK1756273T3 (da) Signalpeptid til frembringelse af et polypeptid
ATE521626T1 (de) Fusionsprotein zur inhibierung von gebärmutterhalskrebs
DE60333001D1 (de) Vac-bac-shuttlevektor-system
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
ATE441865T1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.